{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:53:13Z","timestamp":1788403993131,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82102818"],"award-info":[{"award-number":["No. 82102818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01824-4","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:13:58Z","timestamp":1785147238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TRIM27-Cas9\u2013loaded EVs suppress HCC proliferation and enhance responsiveness to anti\u2013PD-1 therapy by promoting ACSL4-mediated ferroptosis"],"prefix":"10.1038","author":[{"given":"Jie","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9547-9074","authenticated-orcid":false,"given":"Zhirui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0614-9572","authenticated-orcid":false,"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Ashrafizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-8475","authenticated-orcid":false,"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-755X","authenticated-orcid":false,"given":"Wenpeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1824_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1824_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000430","volume":"8","author":"AG Singal","year":"2024","unstructured":"Singal AG, Yarchoan M, Yopp A, Sapisochin G, Pinato DJ, Pillai A. Neoadjuvant and adjuvant systemic therapy in HCC: current status and the future. Hepatol Commun. 2024;8:e0430.","journal-title":"Hepatol Commun"},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180\u201397.","journal-title":"Cancer Cell"},{"key":"1824_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"1824_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/cac2.70044","volume":"45","author":"S Zhu","year":"2025","unstructured":"Zhu S, Zhang X, Liu W, Zhou Z, Xiong S, Li J, et al. Ubiquitination in cancer: mechanisms and therapeutic opportunities. Cancer Commun. 2025;45:1128\u201361.","journal-title":"Cancer Commun"},{"key":"1824_CR6","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.3390\/molecules26216682","volume":"26","author":"S Toma-Fukai","year":"2021","unstructured":"Toma-Fukai S, Shimizu T. Structural diversity of ubiquitin E3 ligase. Molecules. 2021;26:6682.","journal-title":"Molecules"},{"key":"1824_CR7","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/cells13242107","volume":"13","author":"W Wu","year":"2024","unstructured":"Wu W, Yang J, Yu T, Zou Z, Huang X. The role and mechanism of TRIM proteins in gastric cancer. Cells. 2024;13:2107.","journal-title":"Cells"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/biomedicines9030241","volume":"9","author":"F Marzano","year":"2021","unstructured":"Marzano F, Caratozzolo MF, Pesole G, Sbis\u00e0 E, Tullo A. TRIM proteins in colorectal cancer: TRIM8 as a promising therapeutic target in chemo resistance. Biomedicines. 2021;9:241.","journal-title":"Biomedicines"},{"key":"1824_CR9","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/ijms20071776","volume":"20","author":"A Valletti","year":"2019","unstructured":"Valletti A, Marzano F, Pesole G, Sbis\u00e0 E, Tullo A. Targeting chemoresistant tumors: could TRIM proteins-p53 axis be a possible answer? Int J Mol Sci. 2019;20:1776.","journal-title":"Int J Mol Sci"},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2025.05.393","volume":"237","author":"N Noguchi","year":"2025","unstructured":"Noguchi N, Saito Y, Niki E. Lipid peroxidation, ferroptosis, and antioxidants. Free Radic Biol Med. 2025;237:228\u201338.","journal-title":"Free Radic Biol Med"},{"key":"1824_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cells12050804","volume":"12","author":"MS Mortensen","year":"2023","unstructured":"Mortensen MS, Ruiz J, Watts JL. Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells. 2023;12:804.","journal-title":"Cells"},{"key":"1824_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101171","volume":"78","author":"Z He","year":"2025","unstructured":"He Z, Zheng D, Li F, Chen L, Wu C, Zeng Z, et al. TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4. Drug Resist Updat. 2025;78:101171.","journal-title":"Drug Resist Updat"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","volume":"41","author":"Y Lu","year":"2022","unstructured":"Lu Y, Chan YT, Tan HY, Zhang C, Guo W, Xu Y, et al. Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41:3.","journal-title":"J Exp Clin Cancer Res"},{"key":"1824_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02285-x","volume":"23","author":"Y Tian","year":"2025","unstructured":"Tian Y, Bao X, Lei S, Huang Y, Wang X, Tu Y, et al. In vivo CRISPR screening identifies POU3F3 as a novel regulator of ferroptosis resistance in hepatocellular carcinoma via retinoic acid signaling. Cell Commun Signal. 2025;23:329.","journal-title":"Cell Commun Signal"},{"key":"1824_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.115015","volume":"247","author":"Y Gu","year":"2023","unstructured":"Gu Y, Li Y, Wang J, Zhang L, Zhang J, Wang Y. Targeting ferroptosis: paving new roads for drug design and discovery. Eur J Med Chem. 2023;247:115015.","journal-title":"Eur J Med Chem"},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41594-025-01682-7","volume":"32","author":"DA Pratt","year":"2025","unstructured":"Pratt DA, Dixon SJ. A guide to using small-molecule ferroptosis inhibitors. Nat Struct Mol Biol. 2025;32:1848\u201351.","journal-title":"Nat Struct Mol Biol"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315:1709\u201312.","journal-title":"Science"},{"key":"1824_CR19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816\u201321.","journal-title":"Science"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339:819\u201323.","journal-title":"Science"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd.2016.280","volume":"16","author":"H Yin","year":"2017","unstructured":"Yin H, Kauffman KJ, Anderson DG. Delivery technologies for genome editing. Nat Rev Drug Discov. 2017;16:387\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7150\/thno.47007","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang S, Shen J, Li D, Cheng Y. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing. Theranostics. 2021;11:614\u201348.","journal-title":"Theranostics"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1534\/g3.117.041277","volume":"7","author":"T Hart","year":"2017","unstructured":"Hart T, Tong AHY, Chan K, Van Leeuwen J, Seetharaman A, Aregger M, et al. Evaluation and design of genome-wide CRISPR\/SpCas9 knockout screens. G3. 2017;7:2719\u201327.","journal-title":"G3"},{"key":"1824_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70130","volume":"14","author":"Y Pan","year":"2025","unstructured":"Pan Y, Yang X, Zeng Z, Liu F, Luo J, Shen M, et al. 124I-labelled BMSC-derived extracellular vesicles deliver CRISPR\/Cas9 ribonucleoproteins with a GFP-reporter system to inhibit osteosarcoma proliferation and metastasis. J Extracell Vesicles. 2025;14:e70130.","journal-title":"J Extracell Vesicles"},{"key":"1824_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07135-1","volume":"15","author":"SY Chen","year":"2024","unstructured":"Chen SY, Wu J, Chen Y, Wang YE, Setayeshpour Y, Federico C, et al. NINJ1 regulates ferroptosis via xCT antiporter interaction and CoA modulation. Cell Death Dis. 2024;15:755.","journal-title":"Cell Death Dis"},{"key":"1824_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-023-02865-0","volume":"42","author":"J Huang","year":"2023","unstructured":"Huang J, Pan H, Sun J, Wu J, Xuan Q, Wang J, et al. TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages. J Exp Clin Cancer Res. 2023;42:286.","journal-title":"J Exp Clin Cancer Res"},{"key":"1824_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","volume":"3","author":"T Zhang","year":"2022","unstructured":"Zhang T, Sun L, Hao Y, Suo C, Shen S, Wei H, et al. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat Cancer. 2022;3:75\u201389.","journal-title":"Nat Cancer"},{"key":"1824_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen M, Mao A, Xu M, Weng Q, Mao J, Ji J. CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett. 2019;447:48\u201355.","journal-title":"Cancer Lett"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2023.06.005","volume":"44","author":"R Kim","year":"2023","unstructured":"Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment. Trends Pharmacol Sci. 2023;44:542\u201352.","journal-title":"Trends Pharmacol Sci"},{"key":"1824_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1520570","volume":"15","author":"Y Fan","year":"2024","unstructured":"Fan Y, Ma K, Lin Y, Ren J, Peng H, Yuan L, et al. Immune imbalance in Lupus Nephritis: the intersection of T-Cell and ferroptosis. Front Immunol. 2024;15:1520570.","journal-title":"Front Immunol"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26:165\u201376.","journal-title":"Trends Cell Biol"},{"key":"1824_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110994","volume":"114","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wei T, Guo D. The role of abnormal ubiquitination in hepatocellular carcinoma pathology. Cell Signal. 2024;114:110994.","journal-title":"Cell Signal"},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.7150\/ijbs.113193","volume":"21","author":"X Mi","year":"2025","unstructured":"Mi X, Li Q, Long G, Pan Y, Xie Y, Lu S, et al. Deubiquitylating enzymes in hepatocellular carcinoma. Int J Biol Sci. 2025;21:4270\u201392.","journal-title":"Int J Biol Sci"},{"key":"1824_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115538","volume":"167","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhou Y, Feng J, Xu X, Wu J, Guo C. Deciphering roles of TRIMs as promising targets in hepatocellular carcinoma: current advances and future directions. Biomed Pharmacother. 2023;167:115538.","journal-title":"Biomed Pharmacother"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30:137\u201351.","journal-title":"Cell Death Differ"},{"key":"1824_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000246","volume":"7","author":"MR Liu","year":"2023","unstructured":"Liu MR, Shi C, Song QY, Kang MJ, Jiang X, Liu H, et al. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma. Hepatol Commun. 2023;7:e0246.","journal-title":"Hepatol Commun"},{"key":"1824_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/0118715206342278241008081126","volume":"25","author":"S Jin","year":"2025","unstructured":"Jin S, Wang H, Zhang Z, Yan M. Targeting ferroptosis: small-molecule inducers as novel anticancer agents. Anticancer Agents Med Chem. 2025;25:517\u201332.","journal-title":"Anticancer Agents Med Chem"},{"key":"1824_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104203","volume":"193","author":"X Tang","year":"2024","unstructured":"Tang X, Niu Y, Jian J, Guo Y, Wang Y, Zhu Y, et al. Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy. Crit Rev Oncol Hematol. 2024;193:104203.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1824_CR40","first-page":"84","volume":"14","author":"B Gan","year":"2023","unstructured":"Gan B. How erastin assassinates cells by ferroptosis revealed. Protein Cell. 2023;14:84\u201386.","journal-title":"Protein Cell"},{"key":"1824_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00018-025-05812-8","volume":"82","author":"X Ding","year":"2025","unstructured":"Ding X, Cui L, Mi Y, Hu J, Cai Z, Tang Q, et al. Ferroptosis in cancer: revealing the multifaceted functions of mitochondria. Cell Mol Life Sci. 2025;82:277.","journal-title":"Cell Mol Life Sci"},{"key":"1824_CR42","doi-asserted-by":"publisher","first-page":"13121","DOI":"10.3390\/ijms252313121","volume":"25","author":"K Wu","year":"2024","unstructured":"Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, et al. Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches. Int J Mol Sci. 2024;25:13121.","journal-title":"Int J Mol Sci"},{"key":"1824_CR43","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2147\/DDDT.S472178","volume":"18","author":"Y Luo","year":"2024","unstructured":"Luo Y, Bai XY, Zhang L, Hu QQ, Zhang N, Cheng JZ, et al. Ferroptosis in cancer therapy: mechanisms, small molecule inducers, and novel approaches. Drug Des Devel Ther. 2024;18:2485\u2013529.","journal-title":"Drug Des Devel Ther"},{"key":"1824_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114087","volume":"181","author":"H Bloomer","year":"2022","unstructured":"Bloomer H, Khirallah J, Li Y, Xu Q. CRISPR\/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells. Adv Drug Deliv Rev. 2022;181:114087.","journal-title":"Adv Drug Deliv Rev"},{"key":"1824_CR45","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1016\/j.apsb.2021.01.007","volume":"11","author":"J Lu","year":"2021","unstructured":"Lu J, Liu J, Guo Y, Zhang Y, Xu Y, Wang X. CRISPR-Cas9: a method for establishing rat models of drug metabolism and pharmacokinetics. Acta Pharm Sin B. 2021;11:2973\u201382.","journal-title":"Acta Pharm Sin B"},{"key":"1824_CR46","doi-asserted-by":"crossref","unstructured":"Tan M, Ge Y, Wang X, Wang Y, Liu Y, He F, et al. Extracellular vesicles (EVs) in tumor diagnosis and therapy. Technol Cancer Res Treat. 2023; 22:15330338231171463.","DOI":"10.1177\/15330338231171463"},{"key":"1824_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12343","volume":"12","author":"JA Whitley","year":"2023","unstructured":"Whitley JA, Cai H. Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing. J Extracell Vesicles. 2023;12:e12343.","journal-title":"J Extracell Vesicles"},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.32662","volume":"77","author":"X Liu","year":"2023","unstructured":"Liu X, Tan S, Liu H, Jiang J, Wang X, Li L, et al. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology. 2023;77:1181\u201397.","journal-title":"Hepatology"},{"key":"1824_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"S Keshavarz Azizi Raftar","year":"2021","unstructured":"Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, et al. The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spectr. 2021;9:e0048421.","journal-title":"Microbiol Spectr"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01824-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:22:52Z","timestamp":1785518572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01824-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":49,"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01824-4","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The Human Research Ethics Review Committee of Guizhou Medical University approved the application of these clinical samples, which was performed according to the tenets of the Declaration of Helsinki with approval number [2025264]. The process of animal experiments was approved by Animal Ethics Committee of Guizhou Medical University with approval number [2503430].","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}